MedTrace Logo

Bisphenol A and Muscle Insulin Sensitivity

NCT03771066 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-07-08

No results posted yet for this study

Summary

This study examine oral bisphenol A consumption on muscle insulin sensitivity and hepatic glucose suppression. Half of the participants will receive a diet plus BPA and the other half will receive a diet plus no bisphenol A.

Conditions

  • Insulin Sensitivity
  • Glucose Metabolism Disorders
  • Microtia

Interventions

BEHAVIORAL

bisphenol A

Vanilla wafer cookie with bisphenol A administered

BEHAVIORAL

Placebo

Vanilla wafer cookie with no bisphenol A

Sponsors & Collaborators

Principal Investigators

  • Todd Hagobian, PhD · California Polytechnic State University-San Luis Obispo

  • Hannah Brunner-Gaydos · California Polytechnic State University-San Luis Obispo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03771066 on ClinicalTrials.gov